SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-055908
Filing Date
2020-10-27
Accepted
2020-10-27 16:00:10
Documents
2
Period of Report
2020-10-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1606
2 POA DOCUMENT poa.txt EX-24.3_942534 3358
  Complete submission text file 0001209191-20-055908.txt   6615
Mailing Address C/O 3200 WALNUT ST BOULDER CO 80301
Business Address
Robbins Andrew R (Reporting) CIK: 0001590157 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 201264123

Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations